These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 14730473)
21. When can the patient with deep venous thrombosis begin to ambulate? Aldrich D; Hunt DP Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299 [No Abstract] [Full Text] [Related]
22. Antithrombotic therapy and survival in cancer patients. Kakkar AK Best Pract Res Clin Haematol; 2009 Mar; 22(1):147-51. PubMed ID: 19285281 [TBL] [Abstract][Full Text] [Related]
23. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants. DeLoughery TG Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670 [TBL] [Abstract][Full Text] [Related]
24. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143 [TBL] [Abstract][Full Text] [Related]
25. Low molecular weight heparins: the optimal treatment for venous thromboembolism. Daskalopoulos ME; Daskalopoulou SS; Liapis CD Curr Med Res Opin; 2004 Jul; 20(7):1001-5. PubMed ID: 15265244 [TBL] [Abstract][Full Text] [Related]
26. Anticoagulants and cancer survival. Piccioli A; Falanga A; Prandoni P Semin Thromb Hemost; 2006 Nov; 32(8):810-3. PubMed ID: 17171594 [TBL] [Abstract][Full Text] [Related]
27. Antithrombotic therapy with low molecular weight heparin in cancer patients. Petralia P; Kakkar AK Eur J Med Res; 2004 Mar; 9(3):119-24. PubMed ID: 15096321 [TBL] [Abstract][Full Text] [Related]
31. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature]. Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252 [TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism and cancer: prevention and therapy. Lee AY Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461 [TBL] [Abstract][Full Text] [Related]
34. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis. Holzheimer RG Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403 [TBL] [Abstract][Full Text] [Related]
35. Venous thromboembolism: a review of risk and prevention in colorectal surgery patients. Bergqvist D Dis Colon Rectum; 2006 Oct; 49(10):1620-8. PubMed ID: 17019655 [TBL] [Abstract][Full Text] [Related]
36. Management of deep vein thrombosis in cancer patients. Jahanzeb M J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114 [No Abstract] [Full Text] [Related]
37. Use of low-molecular-weight heparins in the treatment and secondary prevention of cancer-associated thrombosis. Grande C; Caparro M Semin Oncol Nurs; 2005 Nov; 21(4 Suppl 1):41-9. PubMed ID: 16360897 [TBL] [Abstract][Full Text] [Related]
38. Low molecular weight heparins in cardiovascular medicine. De Lorenzo F; Dotsenko O; Kakkar VV Minerva Cardioangiol; 2005 Dec; 53(6):585-603. PubMed ID: 16333240 [TBL] [Abstract][Full Text] [Related]
39. Low-molecular-weight heparins for the long-term treatment of cancer patients with venous thromboembolism. Prandoni P J Support Oncol; 2006 Mar; 4(3):127-8. PubMed ID: 16553138 [No Abstract] [Full Text] [Related]